Pharma channel feed

City of Hope re­brands ac­quired Can­cer Treat­ment Cen­ters of Amer­i­ca net­work un­der its own name

3 years ago
Marketing

No­vo Nordisk notch­es big GLP-1 sales amid re­bound­ing sup­plies, but cau­tions on fu­ture 'pe­ri­od­ic con­straints'

3 years ago
Marketing

Go­ing block­buster hunt­ing, Vas Narasimhan out­lines vi­sion for ‘pure-play’ No­var­tis

3 years ago

Pfiz­er brings Ibrance to new sub­set of breast can­cer pa­tients, re­gard­less of menopausal sta­tus

3 years ago
FDA+

2022 was about ex­e­cu­tion. Now will Am­gen's growth strat­e­gy prove its worth?

3 years ago

New com­peti­tors push Sanofi to of­fer vol­un­tary re­tire­ment pack­ages at two In­di­an sites

3 years ago
People
Manufacturing

Pfiz­er's Al­bert Bourla spells out 'tran­si­tion year' for Covid prod­ucts, with sales ex­pect­ed to reach a low point

3 years ago

Pfiz­er scores high­est spend­ing dur­ing NFL sea­son among phar­ma ad­ver­tis­ers — iS­pot analy­sis

3 years ago
Marketing

Covid pub­lic health emer­gen­cies to end in May, but FDA's EUA au­thor­i­ty will con­tin­ue

3 years ago
FDA+
Coronavirus

Mar­ket­ingRx roundup: Pub­li­cis takes can­cer work­place ef­fort to Su­per Bowl; Phar­ma ad­ver­tis­ers still spend big on TV

3 years ago
Marketing

Vec­tor Bio­Med launch­es with $15M to pro­duce back­logged CAR-T com­po­nent

3 years ago
Financing
Startups

Q&A: No­vo Nordisk mar­ket­ing chief aims to change the con­ver­sa­tion around obe­si­ty, even as so­ci­ety has its own plans

3 years ago
Marketing

No­var­tis' Xo­lair suc­ces­sor hit by an­oth­er PhI­II axe, but food al­ler­gy study con­tin­ues

3 years ago
R&D

Am­gen launch­es the first US Hu­mi­ra biosim­i­lar at two dif­fer­ent list prices

3 years ago

Boehringer In­gel­heim touts pre­ven­tion re­sults in rarest form of pso­ri­a­sis

3 years ago
R&D

As­traZeneca, No­vo Nordisk and Sanofi score 340B-re­lat­ed ap­peals court win over HHS

3 years ago
Law

Roche’s Genen­tech de­buts next it­er­a­tion of MS cam­paign, high­lights ex­pe­ri­ences in Black com­mu­ni­ty

3 years ago
Marketing

IRA's price ne­go­ti­a­tion pro­vi­sion would've saved Medicare $26.5B from 2018 to 2020, JA­MA study says

3 years ago

Ap­peals court toss­es J&J's con­tro­ver­sial 'Texas two-step' bank­rupt­cy case

3 years ago
Law

Or­a­cle ex­ec­u­tive Troy Tazbaz named new FDA di­rec­tor of dig­i­tal health

3 years ago
People
FDA+

Up­dat­ed: $100B+ in sav­ings? Why the in­com­ing Hu­mi­ra biosim­i­lars will take time to catch on

3 years ago

Am­gen lays off about 300 work­ers, cit­ing 'in­dus­try head­wind­s'

3 years ago
People

Bris­tol My­ers, Charles Riv­er join Se­ries A fund­ing for iVex­Sol

3 years ago
Financing
Manufacturing

Up­dat­ed: Sam­sung Bi­o­log­ics spells out ex­pan­sion plans in South Ko­rea and US

3 years ago
Manufacturing
First page Previous page 148149150151152153154 Next page Last page
A service from the Financial Times